Symbicort TURBUHALER 160/4.5 µg Twice Daily
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Symbicort TURBUHALER 160/4.5 µg Twice Daily, covering 2011-01-24 to 2011-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients [Phase 3]